Impact of left ventricular diastolic dysfunction on long-term outcome in patients with lower extremity artery disease

Koji Yanaka1, Hirokuni Akahori1, Takahiro Imanaka1

  • 1Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

Journal of Cardiology
|January 23, 2020
PubMed

Insights

Left ventricular diastolic dysfunction significantly increases the risk of major adverse cardiac and cerebrovascular events in patients with lower extremity artery disease. This finding highlights the importance of assessing diastolic function in LEAD patients for improved long-term outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Echocardiography

Background:

  • Lower extremity artery disease (LEAD) is a significant cardiovascular risk factor.
  • The impact of left ventricular (LV) diastolic dysfunction on long-term outcomes in LEAD patients remains understudied.
  • Understanding this relationship is crucial for comprehensive patient management.

Purpose of the Study:

  • To investigate the association between LV diastolic dysfunction and long-term outcomes in patients with LEAD.
  • To determine if LV diastolic dysfunction is an independent predictor of major adverse cardiac and cerebrovascular events (MACCE) in this population.

Main Methods:

  • A cohort of 200 LEAD patients with preserved LV systolic function was analyzed.
  • Patients were classified based on the presence or absence of LV diastolic dysfunction using established echocardiographic guidelines.
  • The 3-year cumulative incidence of MACCE (death, heart failure hospitalization, myocardial infarction, stroke) was compared between groups.

Main Results:

  • LV diastolic dysfunction was present in 31% of the studied LEAD patients.
  • The 3-year incidence of MACCE was significantly higher in patients with LV diastolic dysfunction (35%) compared to those without (23%).
  • Multivariate analysis identified LV diastolic dysfunction (HR=1.96) and critical limb ischemia (HR=2.52) as independent predictors of MACCE.

Conclusions:

  • LV diastolic dysfunction is a significant independent predictor of adverse cardiovascular and cerebrovascular events in patients with LEAD.
  • These findings underscore the importance of evaluating LV diastolic function in LEAD patients for risk stratification and improved clinical outcomes.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
282
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
316
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
607
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
247
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
333
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K